LEAP-2, or Liver-Expressed Antimicrobial Peptide 2, plays a significant role in human health and disease. As an antimicrobial peptide, LEAP-2 is essential for the innate immune system, acting as a natural defense against various microbial threats, including bacteria, fungi and viruses. It also functions as an antagonist of ghrelin, a peptide hormone that stimulates appetite and regulates energy balance.
In addition, LEAP-2 helps regulate inflammatory responses and maintain the balance of the intestinal microbiota, thus promoting overall gastrointestinal health. Understanding the function and regulation of LEAP-2 is crucial for developing new therapeutic strategies against infectious diseases, inflammatory conditions and gastrointestinal disorders. LEAP-2 could also serve as a biomarker for certain diseases, facilitating diagnosis and prognosis. Research on LEAP-2 is therefore essential to deepen our understanding of its role in health and disease, with important implications for clinical practice and public health interventions.
In this new Application Note, discover the good performance of LEAP-2, the new ELISA kit from Bertin Bioregeant.
